Junwei Hao Selected Research

Myelin-Oligodendrocyte Glycoprotein

1/2021

Clinical and Imaging Features of Patients With Encephalitic Symptoms and Myelin Oligodendrocyte Glycoprotein Antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junwei Hao Research Topics

Disease

14	Inflammation (Inflammations) 01/2018 - 04/2011
11	Ischemic Stroke 01/2022 - 12/2014
10	Stroke (Strokes) 01/2022 - 09/2014
10	Multiple Sclerosis 12/2019 - 01/2012
9	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2019 - 01/2011
6	Demyelinating Diseases (Demyelinating Disease) 03/2022 - 03/2013
5	Brain Injuries (Brain Injury) 01/2020 - 09/2014
5	Experimental Autoimmune Neuritis 01/2017 - 02/2014
4	Neuroinflammatory Diseases 01/2022 - 10/2016
4	Cerebral Hemorrhage 01/2017 - 09/2014
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 11/2014
3	Neurologic Manifestations (Neurological Manifestations) 01/2021 - 09/2014
3	Cognitive Dysfunction 01/2019 - 09/2015
3	Neoplasms (Cancer) 01/2018 - 12/2015
3	Ischemia 08/2017 - 11/2014
3	Myasthenia Gravis 02/2017 - 12/2009
3	Brain Edema (Cerebral Edema) 01/2017 - 01/2016
3	Brain Ischemia (Cerebral Ischemia) 01/2017 - 11/2014
3	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 01/2011
2	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 10/2016
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 10/2017
2	Glioma (Gliomas) 01/2018 - 02/2013
2	Neuromyelitis Optica (Devic's Disease) 01/2017 - 11/2016
2	Infarction (Infarctions) 01/2016 - 11/2014
2	Reperfusion Injury 01/2016 - 11/2014
1	Atrophy 01/2021
1	Cerebellar Ataxia (Dysmetria) 01/2021
1	Bites and Stings (Sting) 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2019
1	Parkinson Disease (Parkinson's Disease) 08/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Amyloid Plaque 10/2017
1	Brain Infarction 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Guillain-Barre Syndrome 01/2017

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 01/2021 - 06/2011
4	Everolimus FDA Link 01/2019 - 01/2016
4	TOR Serine-Threonine KinasesIBA 01/2017 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2016
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2019 - 10/2016
3	Cholinergic Agents (Cholinergics)IBA 07/2017 - 01/2017
3	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016 - 09/2014
2	AntibodiesIBA 03/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2013
2	Pharmaceutical PreparationsIBA 01/2022 - 10/2016
2	InflammasomesIBA 01/2020 - 01/2019
2	Neuroprotective AgentsIBA 01/2020 - 08/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 06/2011
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2020 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2020
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2019 - 10/2016
2	Messenger RNA (mRNA)IBA 07/2017 - 01/2017
2	Peptides (Polypeptides)IBA 07/2017 - 01/2017
2	Acetylcholine (Acetylcholine Chloride)FDA Link 02/2017 - 01/2017
2	B7-H1 AntigenIBA 01/2017 - 11/2016
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 03/2016 - 01/2013
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2016 - 09/2014
2	Glatiramer Acetate (Copaxone)FDA Link 09/2015 - 02/2014
2	AntigensIBA 02/2014 - 12/2009
2	Nicotine FDA Link 01/2013 - 01/2011
1	Small Cytoplasmic RNAIBA 01/2022
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2020
1	InterferonsIBA 01/2020
1	Interferon Type IIBA 01/2020
1	Mitochondrial Uncoupling ProteinsIBA 12/2019
1	AntioxidantsIBA 12/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2019
1	2,6-dinitrotoluene (DNT)IBA 01/2019
1	fucoidanIBA 08/2018
1	RotenoneIBA 08/2018
1	GTP-Binding Proteins (G-Protein)IBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	vinpocetineIBA 01/2018
1	Biological ProductsIBA 01/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018
1	Interferon-betaIBA 11/2017
1	Amyloid (Amyloid Fibrils)IBA 10/2017
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 08/2017
1	thiamet GIBA 08/2017
1	Glucosamine (Dona)IBA 08/2017
1	AcetylcholinesteraseIBA 07/2017
1	Macrophage Migration-Inhibitory FactorsIBA 07/2017
1	Biomarkers (Surrogate Marker)IBA 07/2017
1	ChemokinesIBA 07/2017
1	PR-957IBA 01/2017
1	LDL CholesterolIBA 01/2017
1	O-GlcNAc transferaseIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Blood Glucose (Blood Sugar)IBA 01/2017
1	Glial Fibrillary Acidic ProteinIBA 01/2017
1	Long Noncoding RNAIBA 01/2017
1	Interleukin-15 (Interleukin 15)IBA 01/2017
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 12/2016
1	LigandsIBA 11/2016
1	Complement Inactivating AgentsIBA 11/2016
1	Complement Factor H (Factor H)IBA 11/2016

Therapy/Procedure

3	Therapeutics 08/2017 - 04/2011
1	Injections 07/2017